Cargando…

Kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in UK Biobank

BACKGROUND: Associations between kidney function and dementia risk are inconclusive. Chronic kidney disease (CKD) severity is determined by levels of both estimated glomerular filtration rate (eGFR) and the urine albumin to creatinine ratio (ACR). However, whether there is a graded increase in demen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Tian-Shin, Clifton, Lei, Collister, Jennifer A., Liu, Xiaonan, Hunter, David J., Littlejohns, Thomas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440913/
https://www.ncbi.nlm.nih.gov/pubmed/37605228
http://dx.doi.org/10.1186/s13195-023-01248-z
_version_ 1785093255777484800
author Yeh, Tian-Shin
Clifton, Lei
Collister, Jennifer A.
Liu, Xiaonan
Hunter, David J.
Littlejohns, Thomas J.
author_facet Yeh, Tian-Shin
Clifton, Lei
Collister, Jennifer A.
Liu, Xiaonan
Hunter, David J.
Littlejohns, Thomas J.
author_sort Yeh, Tian-Shin
collection PubMed
description BACKGROUND: Associations between kidney function and dementia risk are inconclusive. Chronic kidney disease (CKD) severity is determined by levels of both estimated glomerular filtration rate (eGFR) and the urine albumin to creatinine ratio (ACR). However, whether there is a graded increase in dementia risk for worse eGFR in each ACR category is unclear. Also, whether genetic risk for dementia impacts the associations is unknown. The current study aims to investigate the associations between eGFR and albuminuria with dementia risk both individually and jointly, whether the associations vary by different follow-up periods, and whether genetic factors modified the associations. METHODS: In 202,702 participants aged ≥ 60 years from the UK Biobank, Cox proportional-hazards models were used to examine the associations between eGFR and urine albumin creatinine ratio (ACR) with risk of incident dementia. GFR was estimated based on serum creatinine, cystatin C, or both. The models were restricted to different follow-up periods (< 5 years, 5–10 years, and ≥ 10 years) to investigate potential reverse causation. RESULTS: Over 15 years of follow-up, 6,042 participants developed dementia. Decreased kidney function (eGFR < 60 ml/min/1.73m(2)) was associated with an increased risk of dementia (Hazard Ratio [HR] = 1.42, 95% Confidence Interval [CI] 1.28–1.58), compared to normal kidney function (≥ 90 ml/min/1.73m(2)). The strength of the association remained consistent when the models were restricted to different periods of follow-up. The HRs for incident dementia were 1.16 (95% CI 1.07–1.26) and 2.24 (95% CI 1.79–2.80) for moderate (3-30 mg/mmol) and severely increased ACR (≥ 30 mg/mmol) compared to normal ACR (< 3 mg/mmol). Dose–response associations were observed when combining eGFR and ACR, with those in the severest eGFR and ACR group having the greatest risk of dementia (HR = 4.70, 95% CI 2.34–9.43). APOE status significantly modified the association (p = 0.04), with stronger associations observed among participants with a lower genetic risk of dementia. There was no evidence of an interaction between kidney function and non-APOE polygenic risk of dementia with dementia risk (p = 0.42). CONCLUSIONS: Kidney dysfunction and albuminuria were individually and jointly associated with higher dementia risk. The associations were greater amongst participants with a lower genetic risk of dementia based on APOE, but not non-APOE polygenic risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01248-z.
format Online
Article
Text
id pubmed-10440913
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104409132023-08-22 Kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in UK Biobank Yeh, Tian-Shin Clifton, Lei Collister, Jennifer A. Liu, Xiaonan Hunter, David J. Littlejohns, Thomas J. Alzheimers Res Ther Research BACKGROUND: Associations between kidney function and dementia risk are inconclusive. Chronic kidney disease (CKD) severity is determined by levels of both estimated glomerular filtration rate (eGFR) and the urine albumin to creatinine ratio (ACR). However, whether there is a graded increase in dementia risk for worse eGFR in each ACR category is unclear. Also, whether genetic risk for dementia impacts the associations is unknown. The current study aims to investigate the associations between eGFR and albuminuria with dementia risk both individually and jointly, whether the associations vary by different follow-up periods, and whether genetic factors modified the associations. METHODS: In 202,702 participants aged ≥ 60 years from the UK Biobank, Cox proportional-hazards models were used to examine the associations between eGFR and urine albumin creatinine ratio (ACR) with risk of incident dementia. GFR was estimated based on serum creatinine, cystatin C, or both. The models were restricted to different follow-up periods (< 5 years, 5–10 years, and ≥ 10 years) to investigate potential reverse causation. RESULTS: Over 15 years of follow-up, 6,042 participants developed dementia. Decreased kidney function (eGFR < 60 ml/min/1.73m(2)) was associated with an increased risk of dementia (Hazard Ratio [HR] = 1.42, 95% Confidence Interval [CI] 1.28–1.58), compared to normal kidney function (≥ 90 ml/min/1.73m(2)). The strength of the association remained consistent when the models were restricted to different periods of follow-up. The HRs for incident dementia were 1.16 (95% CI 1.07–1.26) and 2.24 (95% CI 1.79–2.80) for moderate (3-30 mg/mmol) and severely increased ACR (≥ 30 mg/mmol) compared to normal ACR (< 3 mg/mmol). Dose–response associations were observed when combining eGFR and ACR, with those in the severest eGFR and ACR group having the greatest risk of dementia (HR = 4.70, 95% CI 2.34–9.43). APOE status significantly modified the association (p = 0.04), with stronger associations observed among participants with a lower genetic risk of dementia. There was no evidence of an interaction between kidney function and non-APOE polygenic risk of dementia with dementia risk (p = 0.42). CONCLUSIONS: Kidney dysfunction and albuminuria were individually and jointly associated with higher dementia risk. The associations were greater amongst participants with a lower genetic risk of dementia based on APOE, but not non-APOE polygenic risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01248-z. BioMed Central 2023-08-21 /pmc/articles/PMC10440913/ /pubmed/37605228 http://dx.doi.org/10.1186/s13195-023-01248-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yeh, Tian-Shin
Clifton, Lei
Collister, Jennifer A.
Liu, Xiaonan
Hunter, David J.
Littlejohns, Thomas J.
Kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in UK Biobank
title Kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in UK Biobank
title_full Kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in UK Biobank
title_fullStr Kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in UK Biobank
title_full_unstemmed Kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in UK Biobank
title_short Kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in UK Biobank
title_sort kidney function, albuminuria, and their modification by genetic factors and risk of incident dementia in uk biobank
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440913/
https://www.ncbi.nlm.nih.gov/pubmed/37605228
http://dx.doi.org/10.1186/s13195-023-01248-z
work_keys_str_mv AT yehtianshin kidneyfunctionalbuminuriaandtheirmodificationbygeneticfactorsandriskofincidentdementiainukbiobank
AT cliftonlei kidneyfunctionalbuminuriaandtheirmodificationbygeneticfactorsandriskofincidentdementiainukbiobank
AT collisterjennifera kidneyfunctionalbuminuriaandtheirmodificationbygeneticfactorsandriskofincidentdementiainukbiobank
AT liuxiaonan kidneyfunctionalbuminuriaandtheirmodificationbygeneticfactorsandriskofincidentdementiainukbiobank
AT hunterdavidj kidneyfunctionalbuminuriaandtheirmodificationbygeneticfactorsandriskofincidentdementiainukbiobank
AT littlejohnsthomasj kidneyfunctionalbuminuriaandtheirmodificationbygeneticfactorsandriskofincidentdementiainukbiobank